Ok, thinking caps on. so read this part in the conclusion - We further combined our vaccine with immune checkpoint inhibition targeting PD-L1 and demonstrated enhanced antitumor responses when vaccinating therapeutically
So who makes a PD-L1 inhibitor?
"Take a Closer Look", page-539
-
- There are more pages in this discussion • 689 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.75 |
Change
-0.160(0.89%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.65 | $53.47K | 2.992K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 285 | $17.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.75 | 2141 | 1 |
View Market Depth
| Last trade - 15.58pm 16/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |